🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.

RecruitingNAAges 18 Years - anyAllCharles University, Czech Republic
NCT06198400 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Main goal of this study is to evaluate the blood flow in a post resection pancreatic remnant after pancreaticoduodenectomy with use of indocyanine green fluorescence. If the hypothesis will be proven, evaluation of perfusion of the pancreatic remnant with indocyanine green could be used to estimate the increased risk of the development of pancreatic fistula.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All consecutive patients undergoing open pancreaticoduodenectomy at our department in the selected period Exclusion Criteria: * Allergy to indocyanine green * Refusal by the patient * Mini-invasive procedure.
💊

What it tests

  • Perioperative assessment of the perfusion of post-resection pancreatic remnant using indocyanine green-VerDye
📍

Where

1 site
Department of Surgery, Second Faculty of Medicine of Charles University and Military University Hospital Prague, Czech Republic
Prague, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy